Skip to main content
. 2011 Jan 13;12:8. doi: 10.1186/1471-2350-12-8

Table 1.

Detection of the mtDNA 4,977 bp deletion in tumor and non-tumor tissues of 104 colorectal cancer patients.

N Deletion detected in non-tumor tissues p-value OR (95% CI) Deletion detected in tumor tissues p-value OR (95% CI)
Cases 104 13 (12.50%) 17 (16.35%)
Age
 ≤65 48 7 (14.58%) 0.552 1.423 12 (25.00%) 0.027* 3.400
 >65 56 6 (10.71%) (0.443-4.566) 5 (8.93%) (1.101-10.495)
BMI#
 <18 3 0 0.248 -- 0 0.286 --
 18-24 65 8 (11.76%) 11 (16.18%)
 ≥24 25 5 (20.00%) 6 (24.00%)
Differentiation#
 Poor 22 2 (9.09%) 0.772 0.590 3 (13.64%) 0.813 0.680
 Moderate 69 10 (14.49%) (0.119-2.924) 13 (18.84%) (0.175-2.647)
LN metastasis
 Positive 43 8 (18.60%) 0.114 2.560 8 (18.60%) 0.601 1.321
 Negative 61 5 (8.20%) (0.775-8.453) 9 (14.75%) (0.465-3.753)
Stage
 I+II 60 5 (8.33%) 0.134 0.409 9 (15.00%) 0.665 0.794
 III+IV 44 8 (18.18%) (0.124-1.350) 8 (18.18%) (0.280-2.255)

N, case number; BMI, body mass index; Differentiation, tumor cell differentiation status; LN metastasis, lymph node metastasis; Stage, cancer stage classified according to the tumor-node-metastasis (TNM) staging system (American Joint Committee on Cancer); OR, odds ratio; P-values were calculated by chi-square test, * statistically significant; 95% CI, 95% confidence interval; # incomplete data.